Tower Research Capital (TRC)’s Cellcom Israel, Ltd. CEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-141
Closed -$1K 6332
2021
Q1
$1K Buy
+141
New +$629 ﹤0.01% 5343
2020
Q1
Sell
-179
Closed -$1K 4343
2019
Q4
$1K Buy
+179
New +$485 ﹤0.01% 3394
2018
Q4
Sell
-371
Closed -$3K 4614
2018
Q3
$3K Sell
371
-450
-55% -$2.67K ﹤0.01% 3371
2018
Q2
$5K Sell
821
-925
-53% -$6.28K ﹤0.01% 3098
2018
Q1
$12K Buy
1,746
+338
+24% +$2.92K ﹤0.01% 2411
2017
Q4
$14K Buy
1,408
+810
+135% +$7.86K ﹤0.01% 2349
2017
Q3
$6K Buy
598
+119
+25% +$1.09K ﹤0.01% 3282
2017
Q2
$5K Sell
479
-533
-53% -$5.26K ﹤0.01% 2039
2017
Q1
$10K Sell
1,012
-5
-0.5% -$51 ﹤0.01% 1801
2016
Q4
$8K Sell
1,017
-2,697
-73% -$21K ﹤0.01% 2808
2016
Q3
$28K Buy
3,714
+3,435
+1,231% +$25K ﹤0.01% 1440
2016
Q2
$2K Buy
279
+179
+179% +$1.32K ﹤0.01% 4021
2016
Q1
$0 Sell
100
-2,461
-96% -$15.6K ﹤0.01% 5270
2015
Q4
$16K Buy
2,561
+1,719
+204% +$12K ﹤0.01% 1563
2015
Q3
$5K Sell
842
-181
-18% -$1.07K ﹤0.01% 2852
2015
Q2
$4K Sell
1,023
-1,169
-53% -$5.09K ﹤0.01% 3437
2015
Q1
$11K Buy
2,192
+2,138
+3,959% +$12.2K ﹤0.01% 2731
2014
Q4
$0 Sell
54
-532
-91% -$5.19K ﹤0.01% 4966
2014
Q3
$6K Buy
586
+399
+213% +$4.73K ﹤0.01% 3208
2014
Q2
$2K Sell
187
-647
-78% -$8.48K ﹤0.01% 3506
2014
Q1
$11K Sell
834
-2,174
-72% -$28K ﹤0.01% 2539
2013
Q4
$42K Sell
3,008
-875
-23% -$11.1K 0.01% 1548
2013
Q3
$43K Buy
3,883
+3,583
+1,194% +$38.4K ﹤0.01% 2055
2013
Q2
$3K Buy
+300
New +$2.72K ﹤0.01% 3357

Other funds holding CEL

Tower Research Capital (TRC)'s CEL Position: Q2 2021 in Review

Tower Research Capital (TRC) sold out of Cellcom Israel, Ltd. (CEL) in Q2 2021, closing a stake of 141 shares — an estimated $1K sold.

Tower Research Capital (TRC) first reported a position in CEL in Q2 2013 and held it in 24 quarters. The position peaked at $43K in Q3 2013. 3 funds tracked by Wall St. Rank hold CEL as of Q2 2021.

  • Tower Research Capital (TRC) reported no remaining Cellcom Israel, Ltd. position as of Q2 2021 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 141 Cellcom Israel, Ltd. shares in Q2 2021, an estimated $1K.
  • Tower Research Capital (TRC) first reported a position in Cellcom Israel, Ltd. in Q2 2013 and held it in 24 quarters.
  • Tower Research Capital (TRC)'s Cellcom Israel, Ltd. position peaked at $43K in Q3 2013.
  • 3 funds tracked by Wall St. Rank held Cellcom Israel, Ltd. as of Q2 2021.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.